BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
See today's BioWorld Asia
Home
» Other news to note for March 30, 2021
To read the full story,
subscribe
or
sign in
.
Other news to note for March 30, 2021
March 30, 2021
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Ajinomoto, Allianthera, Ascentage, Biontech, Bright Peak, CDC, Cerecor, Cipla, Clinuvel, Curevac, Evelo, Exagen, Fairjourney Biologics, Hoth, Hutchison China Meditech, Immunoprecise Antibodies, Insilico Medicine, Iontas, Johnson & Johnson, Kaleido, Kazia, Kyowa Kirin, Menarini, Mitsubishi Tanabe, Moderna, Neurobo, Nippon Shinyaku, Nobelpharma, Novadiscovery, Open Orphan, Pfizer, Pierre Fabre, Probiogen, RDIF, Sanofi, Siga Technologies, Simcere, Takeda, Twist, Y-Biologics, Zenas.
BioWorld Asia
Briefs
Other news to note